WBR0110: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |QuestionAuthor=William J Gibson |ExamType=USMLE Step 1 |MainCategory=Genetics |SubCategory=Cardiology, Musculoskeletal/Rheumatology |MainCategory=Genetics |SubC...")
 
No edit summary
Line 20: Line 20:
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Cardiology, Musculoskeletal/Rheumatology
|SubCategory=Cardiology, Musculoskeletal/Rheumatology
|Prompt=A 16 year old male presents to his pediatrician to be evaluated for scoliosis.  The physician notes that in addition to his  scoliosis, the patient is unusually tall, and has pectus excavatum.  The physician suspects a genetic origin for the patient’s condition.  Which of the following could potentially be used to treat this patient’s condition?
|Prompt=A 16-year-old male presents to his pediatrician to be evaluated for scoliosis.  The physician notes that in addition to his  scoliosis, the patient is unusually tall, and has pectus excavatum.  The physician suspects a genetic origin for the patient’s condition.  Which of the following could potentially be used to treat this patient’s condition?
|Explanation=The patient in this vignette is suffering from Marfan Syndrome.  Marfan syndrome is a genetic disorder of the connective tissue. People with Marfan tend to be unusually tall, with long limbs and long, thin fingers. Marfan syndrome has a range of expressions, from mild to severe. The most serious complications are defects of the heart valves and aorta.  Marfan syndrome is a dominant genetic trait, meaning that people who inherit only one copy of the Marfan FBN1 gene from either parent will develop Marfan syndrome.  
|Explanation=The patient in this vignette is suffering from [[Marfan syndrome]].  Marfan syndrome is a genetic disorder primarily affecting connective tissue. People with Marfan syndrome tend to be unusually tall, with long limbs and long, thin fingers. Marfan syndrome has a range of [[expressivity]], with clinical symptoms ranging from mild to severe. The most serious complications are typically defects of the heart valves and aorta.  Marfan syndrome is a dominant genetic trait, meaning that people who inherit only one copy of the mutated FBN1 gene from either parent will develop Marfan syndrome.


The syndrome is carried by the gene FBN1, which encodes the connective protein fibrillin-1.  Fibrillin-1 protein is essential for the proper formation of the extracellular matrix, including the biogenesis and maintenance of elastic fibers.  In addition to being a connective protein that forms the structural support for tissues outside the cell, the normal fibrillin-1 protein binds to another protein,transforming growth factor beta (TGF-β). TGF-β has deleterious effects on vascular smooth muscle development and the integrity of the extracellular matrix. Fibrillin-1 directly binds a latent form of TGFβ, keeping it sequestered and unable to exert its biological activity.  Researchers now believe, secondary to mutated fibrillin, excessive TGF-β at the lungs, heart valves, and aorta weakens the tissues and causes the features of Marfan syndrome. Because angiotensin receptor blockers block TGF-Beta activity, they have been used to treat Marfan Syndrome with some efficacy.
The syndrome is carried by the gene FBN1, which encodes the connective protein fibrillin-1.  Fibrillin-1 protein is essential for the proper formation of the extracellular matrix, including the biogenesis and maintenance of elastin fibers.  In addition to being a connective protein that forms the structural support for tissues outside the cell, the normal fibrillin-1 protein binds to an cytokine called transforming growth factor beta (TGF-β). TGF-β signaling has deleterious effects on vascular smooth muscle development and the integrity of the extracellular matrix. Fibrillin-1 directly binds a latent form of TGF-β, keeping it sequestered and unable to exert its biological activity.  Researchers now believe, secondary to mutated fibrillin, excessive TGF-β accumulation in the lungs, heart valves, and aorta weakens the tissues and causes the features of Marfan syndrome.
 
References: First Aid page 90.
 
Tags: #Genetics #Cardiology


Because [[angiotensin receptor blockers]] such as [[losartan]] block TGF-Beta activity, they have been used to treat Marfan Syndrome with some efficacy.
|AnswerA=Losartan
|AnswerA=Losartan
|AnswerAExp=Correct - Angiotensin receptor blockers have been shown to be useful in patient’s with Marfan syndrome.
|AnswerAExp=[[Angiotensin receptor blocker]]s have been shown to be useful in patient’s with Marfan syndrome.
|AnswerB=Lisinopril
|AnswerB=Lisinopril
|AnswerBExp=Incorrect - ACE-inhibitors are used for hypertension and diabetic renal disease.
|AnswerBExp=ACE-inhibitors are used for hypertension and diabetic renal disease.
|AnswerC=Hydrochlorothiazide
|AnswerC=Hydrochlorothiazide
|AnswerCExp=Incorrect - Hydrochlorothiazide is a thiazide diuretic which is used to treat hypercalciuria and nephrogenic diabetes insipidus.
|AnswerCExp=[[Hydrochlorothiazide]] is a thiazide diuretic which is used to treat hypercalciuria and nephrogenic [[diabetes insipidus]].
|AnswerD=Spironolactone
|AnswerD=Spironolactone
|AnswerDExp=Incorrect - Spironolactone is a potassium sparing diuretic and a competitive aldosterone receptor antagonist.  It has antiandrogenic side effects.
|AnswerDExp=[[Spironolactone]] is a potassium sparing diuretic and a competitive aldosterone receptor antagonist.  It has antiandrogenic side effects.
|AnswerE=Furosemide
|AnswerE=Furosemide
|AnswerEExp=Incorrect - Furosemide is a loop diuretic used in the treatment of congestive heart failure and edema.
|AnswerEExp=[[Furosemide]] is a loop diuretic used in the treatment of [[congestive heart failure]] and edema.
|EducationalObjectives=Because angiotensin receptor blockers block TGF-Beta activity, they have been used to treat [[Marfan syndrome]] with some efficacy.
|References=First Aid 2014 page 87
|RightAnswer=A
|RightAnswer=A
|WBRKeyword=Marfan, Marfan's syndrome, Pharmacology, Vascular, Connective tissue, Autosomal dominant, Genetics,
|Approved=Yes
|Approved=Yes
}}
}}

Revision as of 00:46, 26 March 2014

 
Author PageAuthor::William J Gibson
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Genetics
Sub Category SubCategory::Cardiology, SubCategory::Musculoskeletal/Rheumatology
Prompt [[Prompt::A 16-year-old male presents to his pediatrician to be evaluated for scoliosis. The physician notes that in addition to his scoliosis, the patient is unusually tall, and has pectus excavatum. The physician suspects a genetic origin for the patient’s condition. Which of the following could potentially be used to treat this patient’s condition?]]
Answer A AnswerA::Losartan
Answer A Explanation [[AnswerAExp::Angiotensin receptor blockers have been shown to be useful in patient’s with Marfan syndrome.]]
Answer B AnswerB::Lisinopril
Answer B Explanation AnswerBExp::ACE-inhibitors are used for hypertension and diabetic renal disease.
Answer C AnswerC::Hydrochlorothiazide
Answer C Explanation [[AnswerCExp::Hydrochlorothiazide is a thiazide diuretic which is used to treat hypercalciuria and nephrogenic diabetes insipidus.]]
Answer D AnswerD::Spironolactone
Answer D Explanation [[AnswerDExp::Spironolactone is a potassium sparing diuretic and a competitive aldosterone receptor antagonist. It has antiandrogenic side effects.]]
Answer E AnswerE::Furosemide
Answer E Explanation [[AnswerEExp::Furosemide is a loop diuretic used in the treatment of congestive heart failure and edema.]]
Right Answer RightAnswer::A
Explanation [[Explanation::The patient in this vignette is suffering from Marfan syndrome. Marfan syndrome is a genetic disorder primarily affecting connective tissue. People with Marfan syndrome tend to be unusually tall, with long limbs and long, thin fingers. Marfan syndrome has a range of expressivity, with clinical symptoms ranging from mild to severe. The most serious complications are typically defects of the heart valves and aorta. Marfan syndrome is a dominant genetic trait, meaning that people who inherit only one copy of the mutated FBN1 gene from either parent will develop Marfan syndrome.

The syndrome is carried by the gene FBN1, which encodes the connective protein fibrillin-1. Fibrillin-1 protein is essential for the proper formation of the extracellular matrix, including the biogenesis and maintenance of elastin fibers. In addition to being a connective protein that forms the structural support for tissues outside the cell, the normal fibrillin-1 protein binds to an cytokine called transforming growth factor beta (TGF-β). TGF-β signaling has deleterious effects on vascular smooth muscle development and the integrity of the extracellular matrix. Fibrillin-1 directly binds a latent form of TGF-β, keeping it sequestered and unable to exert its biological activity. Researchers now believe, secondary to mutated fibrillin, excessive TGF-β accumulation in the lungs, heart valves, and aorta weakens the tissues and causes the features of Marfan syndrome.

Because angiotensin receptor blockers such as losartan block TGF-Beta activity, they have been used to treat Marfan Syndrome with some efficacy.
Educational Objective: Because angiotensin receptor blockers block TGF-Beta activity, they have been used to treat Marfan syndrome with some efficacy.
References: First Aid 2014 page 87]]

Approved Approved::Yes
Keyword WBRKeyword::Marfan, WBRKeyword::Marfan's syndrome, WBRKeyword::Pharmacology, WBRKeyword::Vascular, WBRKeyword::Connective tissue, WBRKeyword::Autosomal dominant, WBRKeyword::Genetics
Linked Question Linked::
Order in Linked Questions LinkedOrder::